NCT04608396 - Mechanistic Evaluation of Response in TRD (MERIT) | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

July 30, 2021

Study Completion Date

July 30, 2021

Conditions

Treatment Resistant DepressionMajor Depressive Disorder

Interventions

DRUG

AXS-05

AXS-05 taken daily for up to 52 weeks, until relapse.

DRUG

Placebo

Placebo taken daily for up to 52 weeks, until relapse.

Trial Locations (20)

10312

Clinical Research Site, Staten Island

14618

Clinical Research Site, Rochester

19063

Clinical Research Site, Media

27609

Clinical Research Site, Raleigh

28601

Clinical Research Site, Hickory

32801

Clinical Research Site, Orlando

33122

Clinical Research Site, Miami

33161

Clinical Research Site, North Miami

44130

Clinical Research Site, Middleburg Heights

45215

Clinical Research Site, Cincinnati

72209

Clinical Research Site, Little Rock

75243

Clinical Research Site, Dallas

77058

Clinical Research Site, Houston

91403

Clinical Research Site, Sherman Oaks

91786

Clinical Research Site, Upland

92374

Clinical Research Site, Redlands

98201

Clinical Research Site, Everett

606346

Clinical Research Site, Chicago

02131

Clinical Research Site, Boston

08009

Clinical Research Site, Berlin